Pharmacy PGY2 Oncology Residency

• Deadline for application – January 5
• Application materials must be submitted via PhORCAS™
• ASHP Midyear PPS or telephone interview is required prior to application submission
• Interview required (dates to be determined)
• Start date: First or second Monday in July
• Annual salary $60,000
• Benefits include 160 hours of leave for personal time off and conference attendance, 100 hours of sick leave, medical insurance, medical library, medical graphics department, information technology support, office with dedicated computer and references
• Meetings funded include ASHP Midyear Clinical Meeting, Hematology/Oncology Pharmacy Association (HOPA) Annual Meeting
• Numerous board-certified preceptors
• Diverse hematology/oncology learning experiences with tailored instruction for the individual resident based on interests and career goals
• Research project required to be completed with poster presentation at the HOPA Annual Meeting
• Professional presentations: Pharmacy Grand Rounds (ACPE), Oncology Forum, shared student instruction
• Weekend coverage: approximately 12-15 weekends per year
• Teaching certificate program (optional)

Learning experiences are scheduled as 3-5 week experiences or in a longitudinal experience format. Residents are required to meet with the preceptor(s) prior to starting each learning experience to review the goals/objectives and expectations of the learning experience. The resident’s daily responsibilities will be under the direction of the assigned preceptor. 

Required clinical learning experiences include: 

• Inpatient-focused learning experiences
  • Adult Leukemia
  • Lymphoma
  • Stem Cell Transplant
• Outpatient-focused learning experiences
  • Breast Medical Oncology
  • Gastrointestinal Medical Oncology
  • Genitourinary Oncology
  • Gynecology Oncology
  • Multiple Myeloma
  • Thoracic, Head & Neck Medical Oncology
• Combination of inpatient and outpatient learning experiences
  • Melanoma Medical Oncology
• Electives (2) – Pediatrics, Palliative care, Sarcoma, Investigational Cancer Therapeutics, Neuro-oncology, Outpatient Stem Cell Transplant, Outpatient Leukemia or Lymphoma, Infectious Disease, and others
• While on clinical learning experiences, residents will participate in direct patient care activities (rounding, clinic, medication education, etc.) and scheduled topic discussions. Residents will actively work with an assigned preceptor.
• Residents will gain experience with malignant hematology and solid tumor disease states in the inpatient and outpatient settings during the residency year.

Other Required Learning Experiences

• Investigational Pharmacy Services
  • Investigational protocol review
  • Development of drug information forms for investigational agents
  • IRB or Clinical Research Committee meeting attendance

• Drug Information
  • The MD Anderson Drug Information Service is designed to provide information to healthcare providers within MD Anderson and its associated facilities and to outside healthcare providers. This learning experience is completed on a longitudinal basis throughout the residency year. Orientation to the goals, objectives, and learning experiences is typically completed during orientation. As a component of the Drug Information experience, residents will each complete a DI project and present the findings to the P&T or other appropriate committee.

• Professional Pharmacy Practice
  • Participation on the Clinical Medication Safety Committee, which helps to track, review, and report all safety events involving clinical pharmacy staff.
  • Participation in the development or review of policies and procedures, treatment plans, medication guidelines, treatment algorithms, or other project related to our electronic health record.
  • Professional development discussions - all PGY2 residents will participate in longitudinal discussions aimed at facilitating professional development in clinical practice. A variety of preceptors and employees of the Division of Pharmacy will participate in each discussion in order to share different experiences and viewpoints. Examples of these discussions include self-evaluation/professionalism/emotional intelligence/credibility, precepting and mentorship, technology and automation, and pharmacy administration.

Weekend/Holiday Coverage

Residents will provide operations staffing in the Ambulatory Treatment Center (ATC), which will include order entry and verification, as well as chemotherapy preparation. Residents will be assigned to work approximately 12-15 weekends throughout the year, including Thanksgiving or Christmas (but not both) and 1-2 minor holidays throughout the year. During selected weekends, residents will also provide coverage for the non-formulary on call service. 

Research Project

The research project is an ASHP requirement and must be completed prior to completion of the residency program. The project may be administrative, clinical, or quality improvement in focus. A minimum of one preceptor will be assigned to each project to help ensure appropriateness and completion. The project should be appropriate for publication and will be presented at the HOPA annual meeting. Documentation of the research project will include a project description (including background, objectives, methods, and resident's responsibilities) and a final project manuscript complete with results, data analysis, and conclusions.

Presentations and Teaching Opportunities

• Oncology Forum  
  • Oncology forum is held every Tuesday and is attended by pharmacy residents, clinical staff, staff pharmacists, pharmacy students and other health care professionals/trainees. It is designed for residents to facilitate a review and discussion on supportive care topics, chemotherapy agents by class, and cancer disease states. One resident is assigned to each topic and provides an overview of the topic in a discussion format, including a handout. Clinical staff help the resident facilitate the discussion.
• Grand Rounds
  • Each resident is required to present a Grand Rounds to the Division of Pharmacy complete with continuing pharmacy education accreditation (ACPE). This is a formal presentation complete with Audience Response System (ARS) questions, slides, and handout. The audience is primarily pharmacists, but it is open to other health professionals. The resident will select a presentation topic of interest to him/her based on the needs assessment that was conducted per ACPE requirements. Each resident will work with a minimum of one preceptor. The preceptor’s responsibility is to serve as a content expert by reviewing and revising presentation content as well as ensuring deadlines are met by the resident. 
• Education program to general public regarding cancer screening & prevention
  • Residents will participate in the development and delivery of a program for the general public that centers on health improvement, wellness, and screening for and preventing cancer. Residents may accomplish this in a variety of ways: the MD Anderson Ambassador program, participation in health fairs, Cancer Survivors Week, providing education at an appropriate venue, etc. Residents will be responsible for identifying appropriate activities and developing education materials and should work together to meet the goal/objectives. Each resident will participate in at least 1 event during the course of the residency year. 
• Nursing Inservices
  • Residents will gain experience providing education and/or training to health care professionals by providing nursing inservices. Inservices will be assigned to specific clinical learning experiences. Topics may be chosen by the resident or assigned by the preceptor and must be a minimum of 30 minutes in duration.  
• Student Teaching Activities
  • All residents will participate in teaching in Shared Student Instruction, which consists of leading an assigned topic discussion with pharmacy school students on rotation at MD Anderson during each student block (a minimum of 3 times/year).
  • All residents will participate in leading Shared Student Journal Club and Presentations (SSJCP), which allows for pharmacy students to critically evaluate and discuss recent articles with their peers, residents, and clinical pharmacy specialists during their APPE rotations at MD Anderson. All residents will also participate in case presentations, where pharmacy students have the opportunity to deliver a formal presentation in front of an audience of peers, residents, and clinical pharmacy specialists on a topic of their choosing.
  • Residents may have the opportunity to participate in the oncology module for the University of Houston, College of Pharmacy Therapeutics Course by giving a didactic lecture or facilitating case conferences. 

Teaching Certificate Program

The University of Houston College of Pharmacy offers a teaching certificate program to all pharmacy residents in the Houston area. The purpose of the program is to provide a formal training program for pharmacy residents to gain knowledge and to demonstrate effectiveness in the areas of teaching, leadership and scholarship. The program consists of three components: 1) Weekly Seminars 2) Teaching Experience 3) Teaching Portfolio. This is an elective learning activity (not required).

Conference/Seminar Attendance

Residents will attend the following conferences: ASHP Midyear Meeting and HOPA (Hematology/Oncology Pharmacy Association). Residents may attend other conferences designated by the program director.

Residency Program Director

Jason Yeh, Pharm.D., BCOP
Director, PGY2 Oncology Pharmacy Residency Program
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., The University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, UW Medicine
- ASHP-Accredited PGY2 Oncology, UW Medicine

Residency Program Coordinators

Neelam K. Patel, Pharm.D., BCOP
Coordinator, PGY2 Oncology Pharmacy Residency Program
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., Mercer University College of Pharmacy and Health Sciences
- ASHP-Accredited PGY1 Pharmacy Residency, Memorial University Medical Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Katie Highsmith, Pharm.D., BCOP
Coordinator, PGY2 Oncology Pharmacy Residency Program
Clinical Pharmacy Specialist – Neuro-oncology
Training:
- Pharm.D., University of the Pacific, Thomas J. Long School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, VA San Diego Healthcare System
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Breast Medical Oncology Preceptors

Bonnie Boster, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., The Ohio State University
- ASHP-Accredited PGY2 Oncology, South Texas Veterans Health Care System

Erin Grannan, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., Philadelphia College of Pharmacy at the University of Health Sciences
- ASHP-Accredited PGY1 Pharmacy Residency, MedStar Washington Hospital Center
- ASHP-Accredited PGY2 Oncology, Dana-Farber Cancer Institute

Jaime Kaushik, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., University of Iowa College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, University of Illinois at Chicago
- ASHP-Accredited PGY2 Oncology, University of Illinois at Chicago

Jon Malara, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., Philadelphia College of Pharmacy at the University of Health Sciences
- ASHP-Accredited PGY1 Pharmacy Residency, Robert Wood Johnson University Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Alicia McGhie, Pharm.D.
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., University of California, San Diego Skaggs School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Swedish Medical Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

John Patrick (JP) Sanchez, Pharm.D., BCOP
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., The University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Abigail Shockley, Pharm.D.
Clinical Pharmacy Specialist – Breast Medical Oncology
Training:
- Pharm.D., Purdue University College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Medical University of South Carolina
- ASHP-Accredited PGY2 Oncology, Medical University of South Carolina

Gastrointestinal Medical Oncology Preceptors

Wendy Covert, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., University of Houston College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, The Methodist Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Stacy Diao, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., The University of Kansas
- ASHP-Accredited PGY1 Pharmacy Residency, Baylor University Medical Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Andrea Landgraf Oholendt, Pharm.D., BCOP
Clinical Pharmacy Service Manager
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., The University of Arizona College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, The Methodist Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Michael Leung, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., University of Maryland School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Morgan Mace, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., The University of South Carolina College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, UF Health Shands Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Van Nguyen, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., University of Houston College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Saint Francis Health System
- ASHP-Accredited PGY2 Oncology, Audie L Murphy Memorial Veterans Hospital

Jane Rogers, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., West Virginia University
- ASHP-Accredited PGY1 Pharmacy Residency, West Virginia University Hospitals
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Amanda Sirisaengtaksin, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., Texas A&M College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Baylor St. Luke’s Medical Center
- ASHP-Accredited PGY2 Oncology, Henry Ford Health System

Makenna Smack, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., Roseman University of Health Sciences College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Memorial Hermann Hospital System
- ASHP-Accredited PGY2 Oncology, Boston Medical Center

Jennifer Zadlo, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gastrointestinal Medical Oncology
Training:
- Pharm.D., The Univ. of the Sciences in Philadelphia – Philadelphia College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Penn State Milton S. Hershey Med. Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Genitourinary Medical Oncology Preceptors

Henry Cao, Pharm.D., BCPS
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training:
- Pharm.D., University of Houston College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center

Diana Cauley, Pharm.D., BCOP
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training:
- Pharm.D., University of Colorado, Health Science Center
- ASHP-Accredited PGY1 Pharmacy Residency, University of California, San Francisco
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Andrienne Chen, Pharm.D., BCPS
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training:
- Pharm.D., The University of Texas at Austin
- ASHP-Accredited PGY1 Pharmacy Residency, Michael E. DeBakey VA Medical Center

Allison Grana, Pharm.D., BCOP
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training:
- Pharm.D., Purdue University
- ASHP-Accredited PGY1 Pharmacy Residency, The Johns Hopkins Hospital
- ASHP-Accredited PGY2 Oncology, The James Cancer Hospital at The Ohio State Univ.

Emily Wang, Pharm.D., BCOP
Clinical Pharmacy Specialist – Genitourinary Medical Oncology
Training:
- Pharm.D., Texas Tech University Health Science Center – School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, CHI St. Luke’s Health System
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Gynecologic Oncology Preceptors

Aqsa Adnan, Pharm.D.
Clinical Pharmacy Specialist – Gynecologic Oncology
Training:
- Pharm.D., Mercer College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Emory University Hospital Midtown
- ASHP-Accredited PGY2 Oncology, Emory University Hospital Midtown

Donyika Joseph, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gynecologic Oncology
Training:
- Pharm.D., Xavier University School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Our Lady of the Lake Regional Med. Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Dina Patel, Pharm.D.
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Gynecologic Oncology
Training:
- Pharm.D., University of Colorado
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Shrina Patel, Pharm.D., BCOP
Clinical Pharmacy Specialist – Gynecologic Oncology
Training:
- Pharm.D., University of the Sciences in Philadelphia
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Investigational Cancer Therapeutics Preceptors

Stacie Bean, Pharm.D.
Clinical Pharmacy Specialist – Investigational Cancer Therapeutics
Training:
- Pharm.D., Xavier University of Louisiana
- ASHP-Accredited PGY1 Pharmacy Residency, St. Claire Regional Medical Center
- ASHP-Accredited PGY2 Oncology, Emory University Hospital

Keturah Crease, Pharm.D., BCOP
Clinical Pharmacy Specialist – Investigational Cancer Therapeutics
Training:
- Pharm.D., Rutgers, The State University of New Jersey
- ASHP-Accredited Fellowship, Rutgers Pharmaceutical Industry Fellowship Program / Merck & Co., Inc. - Oncology Clinical Development and Medical Affairs

JoAnn Lim, Pharm.D., BCOP
Clinical Pharmacy Specialist – Investigational Cancer Therapeutics
Training:
- Pharm.D., The Ohio State University
- ASHP-Accredited PGY1 Pharmacy Residency, The Ohio State Univ. Hospital and Clinics
- ASHP-Accredited PGY2 Oncology, The Ohio State Univ. Arthur G. James Cancer Center

Hoyt Slade, Pharm.D., BCOP, CMTM
Clinical Pharmacy Specialist – Investigational Cancer Therapeutics
Training:
- Pharm.D., Mercer University Southern School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, UAB Health System
- ASHP-Accredited PGY2 Oncology, UAB Health System

Leukemia Preceptors

Jeff Bryan, Pharm.D.
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Georgia, College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Univ. of Alabama at Birmingham Hospital
- ASHP-Accredited PGY2 Oncology, University of Alabama at Birmingham Hospital

Ashley Dinh, Pharm.D.
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Adam DiPippo, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., MCPHS University
- ASHP-Accredited PGY1 Pharmacy Residency, Concord Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Alexandra Lovell, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Iowa College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Carolinas Medical Center
- ASHP-Accredited PGY2 Oncology, Barnes-Jewish Hospital

Kayleigh Marx, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., The University of Georgia College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, University of Kentucky HealthCare
- ASHP-Accredited PGY2 Oncology, University of Kentucky HealthCare

Debbie McCue, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Maryland School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Bronx VAMC
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Dan Nichols, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., Virginia Commonwealth University
- ASHP-Accredited PGY1 Pharmacy Residency, University of Kentucky HealthCare
- ASHP-Accredited PGY2 Oncology, University of Kentucky HealthCare

Shilpa Paul, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Illinois at Chicago – College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Yale-New Haven Hospital
- ASHP-Accredited PGY2 Oncology, Huntsman Cancer Institute

Caitlin Rausch, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Michigan
- ASHP-Accredited PGY1 Pharmacy Residency, University of Michigan Health System
- ASHP-Accredited PGY2 Oncology, University of Michigan Health System

Michael Savoy, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Louisiana at Monroe College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, The Johns Hopkins Hospital
- ASHP-Accredited PGY2 Oncology, The Johns Hopkins Hospital

Jacki Sawyers, Pharm.D., BCOP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of North Carolina at Chapel Hill
- ASHP-Accredited PGY1 Pharmacy Residency, Vanderbilt University Medical Center
- ASHP-Accredited PGY2 Oncology, Northwestern Medicine

Austin Wilson, Pharm.D., BCPS, BCCCP
Clinical Pharmacy Specialist – Leukemia
Training:
- Pharm.D., University of Kansas School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Banner University Medical Center Tucson
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Lymphoma – Myeloma Preceptors

Sheree Chen, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., The University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Texas Tech Univ. Health Sciences
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Russell Clark, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., Texas A&M University Irma Lerma Rangel College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, CHI – Baylor St. Luke’s Medical Center
- ASHP-Accredited PGY2 Oncology, The University of Kansas Health Systems

Bryan Do, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., Regis University School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, UMass Memorial Medical Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Sandy Horowitz, Pharm.D.
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., St. John’s University, College of Pharmacy and Allied Health Professions
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Benjamin Lee, Pharm.D., BCPS
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., University of North Carolina Eshelman School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Moffitt Cancer Center
- ASHP-Accredited PGY2 Oncology, Moffitt Cancer Center

Caitlin Linger, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., The Ohio State University College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Brian Primeaux, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., University of Louisiana at Monroe
- ASHP-Accredited PGY1 Pharmacy Residency, The Johns Hopkins Hospital
- ASHP-Accredited PGY2 Oncology, The Johns Hopkins Hospital

Adrienne Sevin, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., University of Houston College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, St. Luke’s Episcopal Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Mohammad Waleed, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., University of Connecticut School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Johns Hopkins Bayview Medical Center
- ASHP-Accredited PGY2 Oncology, Dartmouth-Hitchcock Medical Center

Chelsea Wong, Pharm.D., BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., University of Houston College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Erin Yeung, Pharm.D., BCPS, BCOP
Clinical Pharmacy Specialist – Lymphoma-Myeloma
Training:
- Pharm.D., The University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, South Texas Veterans Health Care System
- ASHP-Accredited PGY2 Oncology, South Texas Veterans Health Care System

Melanoma and Sarcoma Preceptors

Jaime Anderson, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training:
- Pharm.D., University of Colorado at Denver School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Cleveland Clinic
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Megan Fonteno, Pharm.D.
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training:
- Pharm.D., Auburn University
- ASHP-Accredited PGY1 Pharmacy Residency, Piedmont Columbus Regional Hospital
- ASHP-Accredited PGY2 Oncology, Huntsman Cancer Institute at the University of Utah

Michael Frei, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training:
- Pharm.D., Wayne State University
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Anna Jan, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training:
- Pharm.D., University of California San Francisco, School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, VA Greater Los Angeles Healthcare System
- ASHP-Accredited PGY2 Oncology, H. Lee Moffitt Cancer Center

Jocelyn Joseph, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training:
- Pharm.D., The University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Methodist Healthcare – University Hospital
- ASHP-Accredited PGY2 Oncology, The University of Kansas Hospital

Emma Lodl, Pharm.D.
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training:
- Pharm.D., University of Florida College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, UF Health Shands Hospital
- ASHP-Accredited PGY2 Oncology, UF Health Shands Hospital

Van Trinh, Pharm.D., BCOP
Clinical Pharmacy Specialist – Melanoma and Sarcoma
Training:
- Pharm.D., University of Houston College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Hermann Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Pediatric Oncology Preceptors

Suzanne Gettys, Pharm.D., BCOP
Clinical Pharmacy Specialist – Pediatric Oncology
Training:
- Pharm.D., University of North Carolina Eshelman School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, UAB Hospital
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Estela Mireles, Pharm.D., BCOP
Clinical Pharmacy Specialist – Pediatric Oncology
Training:
- Pharm.D., Texas Tech University Health Sciences Center School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, The University of Texas Medical Branch
- ASHP-Accredited PGY2 Oncology, St. Jude Children’s Research Hospital

Lindsay Robusto, Pharm.D., BCOP
Clinical Pharmacy Specialist – Pediatric Oncology
Training:
- Pharm.D., University of New England College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Johns Hopkins Bayview Medical Center
- ASHP-Accredited PGY2 Oncology, The Johns Hopkins Hospital

Stem Cell Transplantation and Cellular Therapy Preceptors

Telyssa Anderson, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., Texas Tech Health Sciences Center School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, WVU Medicine
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Trace Bartels, Pharm.D.
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., University of Arizona College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Mayo Clinic Hospital
- ASHP-Accredited PGY2 Oncology, Moffitt Cancer Center

Morgan Belling, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., Ohio Northern University – Rudolph H. Raabe College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, WVU Medicine
- ASHP-Accredited PGY2 Oncology, WVU Medicine

Rita Cool, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., The University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Scott & White Memorial Hospital
- ASHP-Accredited PGY2 Oncology, Scott & White Memorial Hospital

David Doan, Pharm.D.
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., Virginia Commonwealth University School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Emory Healthcare
- ASHP-Accredited PGY2 Oncology, Emory Healthcare / Winship Cancer Institute

Vi Doan, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., University of Houston College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Joe Fang, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., The University of Texas at Austin College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Jill Ferguson, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., The University of Texas Health Science Center at San Antonio
- ASHP-Accredited PGY2 Oncology, Audie L Murphy Veterans Hospital

Bradley Figgins, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., University of Florida College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, U.T. MD Anderson Cancer Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Alison Gulbis, Pharm.D., BCOP
Clinical Pharmacy Services Manager
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., University of Florida College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Medical University of South Carolina
- ASHP-Accredited PGY2 Oncology, Medical University of South Carolina

Suhani Mehta, Pharm.D.
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., Purdue University College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Northwestern Memorial Hospital
- ASHP-Accredited PGY2 Oncology, Cleveland Clinic

Terri Lynn Shigle, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., Ohio Northern University
- ASHP-Accredited PGY1 Pharmacy Residency, UPMC Mercy
- ASHP-Accredited PGY2 Oncology, UPMC Shadyside

Whitney Wallis, Pharm.D., BCOP
Clinical Pharmacy Specialist – Stem Cell Transplantation and Cellular Therapy
Training:
- Pharm.D., University of Tennessee Health Sciences Center School of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, Methodist University Hospital
- ASHP-Accredited PGY2 Oncology, UAB Hospital

Thoracic / Head and Neck Medical Oncology Preceptors

Bailee Binks, Pharm.D., BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training:
- Pharm.D., Roseman University of Health Sciences
- ASHP-Accredited PGY1 Pharmacy Residency, Intermountain Healthcare
- ASHP-Accredited PGY2 Oncology, Yale-New Haven Hospital

Whitney Lewis, Pharm.D., BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training:
- Pharm.D., University of Oklahoma College of Pharmacy
- ASHP-Accredited PGY1 Pharmacy Residency, St. John Medical Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

Melvin Rivera, Pharm.D., BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training:
- Pharm.D., Northeastern University, Bouve College of Health Sciences
- ASHP-Accredited PGY1 Pharmacy Residency, Boston Medical Center
- ASHP-Accredited PGY2 Oncology, Boston Medical Center

Karen Wang, Pharm.D., BCOP
Clinical Pharmacy Specialist – Thoracic / Head and Neck Medical Oncology
Training:
- Pharm.D., Rutgers University
- ASHP-Accredited PGY1 Pharmacy Residency, Iowa Methodist Medical Center
- ASHP-Accredited PGY2 Oncology, University of Texas MD Anderson Cancer Center

What is the goal of the residency?
The goal of the PGY2 Oncology Pharmacy Residency Program is to provide the resident with a broad-based exposure and experience with malignant hematology, oncology, and stem cell transplant patient populations. The resident will develop their clinical skills and be prepared to provide clinical pharmacy services in both the acute and ambulatory care settings.

How is the residency offered?
The residency is a one-year program that is heavily weighted in direct patient care. The program consists of core learning experiences and additional requirements but allows for tailored instruction on each individual resident’s interest(s) and career goals.

Is the program accredited by the American Society of Health-System Pharmacists?
Yes, the program received a full-cycle (8 year) re-accreditation by the Commission on Credentialing of the American Society of Health-System Pharmacists in 2018.

Is participation in the ASHP match program required?
Participation in the ASHP match program is required. The ASHP Resident Matching Program code for the MD Anderson Oncology Residency Program is 584060. Please review match requirements and process at www.natmatch.com. For details regarding the residency application process, please visit www.mdanderson.org/pharmacy. The deadline for application submission is January 5.

How many resident positions are available and what are the requirements?
We currently offer 4 PGY2 Oncology Pharmacy Resident positions each year. Requirements include a Pharm.D. degree, successful completion of an ASHP-accredited PGY1 Pharmacy Residency, and Texas Pharmacist licensure no later than October 1.

What should I expect at the time of the interview?
The interview process entails a full day (approximately 8:00 a.m.-4:00 p.m.) of meetings with clinical preceptors, program leadership, and current residents, along with a tour of the facilities. During the interview, candidates will also work-up a patient case that is presented to a group of program preceptors. The purpose of the patient case is to evaluate the candidate’s knowledge base, clinical decision-making skills, and communication skills. More information regarding interview format and process will be provided prior to the interview. Interviews will be conducted in February.

How are residents selected for the residency?
Residents are selected by the Division of Pharmacy based on multiple factors including their past education and training, letters of reference, performance during the interview, and overall match with the PGY2 Oncology Residency Program at MD Anderson. The program director will discuss the matching process and notification of resident selection during the interview.

Does the resident need to be licensed in the state of Texas?
The resident must be eligible for pharmacist licensure in the state of Texas (reciprocity or examination) as soon they are accepted into the program. It is highly recommended that the resident completes all necessary examinations / processes for licensure prior to starting the program in July. It is mandatory that the resident is licensed by the Texas State Board of Pharmacy by October 1 in order to successfully complete the program.

Who is the PGY2 Oncology Residency Program Director and who are the preceptor faculty?
The director of the PGY2 Oncology Pharmacy Residency is Jason Yeh, Pharm.D., BCOP. The residency coordinators are Neelam Patel, Pharm.D., BCOP, and Katie Highsmith, Pharm.D., BCOP. In addition to the Division of Pharmacy and program leadership, there are numerous board certified clinical pharmacy specialists who serve as preceptors for the PGY2 Oncology Pharmacy Residency. This includes specialists in each of the oncology disease sites, drug information, medication safety, investigational pharmacy services, infectious diseases, and pharmacy operations. The preceptor group is dedicated and committed to the continued success of each of our residents and the program overall.

What expectations are placed on the resident?
The resident is expected to make a commitment to satisfactorily complete all requirements of the program, as planned in advance and communicated with the resident upon acceptance into the program. This commitment includes but is not limited to the following: active participation in direct patient care, presentations, weekend coverage, research and other projects as assigned, attendance at required meetings and programs, and the availability and willingness to participate in any function of the Division of Pharmacy on a 24-hour basis. The resident is required to complete documentation and evaluations for all activities, experiences, and objectives accomplished. The resident must meet the criteria of “achieved for residency” for a pre-specified number of goals/objectives in order to successfully complete the program.

What are the service commitments?
In addition to scheduled and elective learning experiences, the resident is required to participate in weekend coverage providing pharmacy operations staffing in the Ambulatory Treatment Center (ATC). Each resident will be scheduled to work approximately 12-15 weekends, including the possibility of one major holiday (Thanksgiving or Christmas) and 1-2 minor holidays. Residents will also participate in non-formulary on call intermittently when providing weekend coverage.

What presentations and publications are expected of the resident?
Throughout the year, the resident will provide 8-10 Oncology Forum presentations, and one program on cancer screening and prevention to the general public. Each resident is required to present a Pharmacy Grand Rounds complete with continuing pharmacy education (ACPE) credit. Residents will be expected to present their research project results as a poster presentation at the annual HOPA (Hematology/Oncology Pharmacy Association) meeting.

How is the resident evaluated?
The PGY2 Oncology pharmacy residency program at MD Anderson is not based upon a set number of "hours" in each experience area. Rather, it is based upon behavioral plus competency-based objectives. During each learning experience, preceptor faculty will provide the resident with weekly informal feedback as well as a formal summative evaluation upon completion of the rotation according to the pre-assigned goals and objectives. Longitudinal learning experiences are evaluated quarterly. Additionally, the resident will evaluate their preceptor and the learning experience upon completion of each individual experience. All learning experience evaluations are documented and maintained in PharmAcademic. Upon completion of the residency program, the resident will be asked to evaluate the overall residency program (i.e., strengths, weaknesses) as well as to provide suggestions for improvement.

What support is offered for educational trips and seminars?
Every attempt is made to financially support travel for the residents to attend relevant educational seminars and programs. Priority programs include ASHP Midyear and HOPA (Hematology/Oncology Pharmacy Association) Annual Meeting.

In what other educational programs does the Division of Pharmacy participate?
The Division of Pharmacy provides case-based Shared Student Instruction and Shared Student Journal Club and Presentations for fourth year pharmacy students completing rotations at MD Anderson (approximately three times/year). Didactic lecture opportunities and a teaching certificate program (both elective) are available through the University of Houston College of Pharmacy. The Division of Pharmacy provides inservice and continuing education programs to the hospital's professional staff. The Division of Pharmacy also offers additional residency programs, including a PGY1 Pharmacy Residency, PGY2 Critical Care Pharmacy Residency, PGY2 Infectious Diseases, PGY2 Medication-Use Safety & Policy, and PGY1/PGY2 Health System Pharmacy Administration Residency.

What stipend and benefit program is offered?
The annual stipend is $60,000. The benefits program includes 160 hours of leave for personal time off and conference attendance, 100 hours of sick leave, and comprehensive health insurance. There is no financial support for moving and living expenses, but relocation information is provided that educational trainees find very beneficial.

What other support is available to the residents during the residency?
The Division of Pharmacy provides lab coats and scrubs to the residents. An office dedicated for pharmacy residents is provided with books and supplies as well as an individual desk, computer, and iPhone support. MD Anderson has its own medical library and also provides on-line access to the Texas Medical Center library both from within and outside of the institution. The institution also has its own medical graphics department to assist in the development of professional poster presentations, as well as a biostatistics department to assist with research endeavors.

What living arrangements are available for the resident?
Houston offers a wide variety of housing opportunities, including many apartments and townhouses near the Texas Medical Center. Many of the surrounding housing opportunities offer a regular shuttle service to the hospital or are close to the light rail system that goes through the Texas Medical Center

What entertainment and cultural opportunities are available in the Houston area?
Houston offers opportunities for enjoyment of the arts, entertainment, sports and recreation. The city offers major league sports, outstanding dining and shopping areas, as well as several special attractions, including the Johnson Space Center, Moody Gardens, the Houston Zoo, Houston Museum of Natural Science, Cynthia Mitchell Woods Pavilion, the Toyota Center, NRG Stadium, Minute Maid Park, Kemah Boardwalk, The Strand in Galveston, and the beaches of the Texas Gulf Coast.

Application Deadline and Requirements:

• An ASHP Midyear PPS or virtual interview is required prior to application submission
  
• If not participating in PPS, please contact the Residency Program Director to set up a virtual interview
• Applications must be submitted via the Phorcas™ system
• Application must be submitted no later than January 5
• Participation in ASHP Resident Matching Program is required for all Residency Programs
• No temporary United States visa sponsorship
  • Immigration visa sponsorship for this program is NOT offered by MD Anderson.  Individuals admitted to this program will be required to demonstrate a valid immigration status prior to the PGY2 residency appointment and it must be for the full period of the PGY2 residency program.

The following application materials must be submitted via the PhORCAS™ online application system by January 5

• A Statement of Intent (not to exceed one typewritten page) describing your career goals and reasons for pursuing the residency program
• Curriculum Vitae
• Official transcript from Pharmacy College/University indicating date of graduation and degree earned (originals required via PhORCAS™)
• Reference Form in PhORCAS™ completed by THREE references
  

In addition to the Reference Form in PhORCAS™, MD Anderson also requires that your THREE references each submit a Formal Letter of Reference

• Directions for Letters of Reference
  • All letters must be on institutional letterhead and must be dated AND contain an original signature.
  • Completed letters can be submitted as follows:

1.       Preferred Method: scan and email the letter (PDF document) directly to PGY2-OncologyResidency@mdanderson.org
2.       Fax the letter to 713-792-5256 – attention Jason Yeh

• The PhORCAS™ “Standardized Reference Form” does not meet our institution/program requirements and cannot be accepted in lieu of reference letters.

Interview Requirements and Scheduling:

• An interview is required.
• All candidates will be notified of their interview status by January 20
• Interviews will be conducted in February, after receipt of all application materials.

Upon release of the match results, candidates who match with our institution will need to complete an institution specific application and requirements for appointment via the MD Anderson DISCOVER™ online application system. The DISCOVER System™ is a web-based database utilized to streamline the application selection and appointment process. More information about this process will be provided at the time of onsite interviews.

For questions regarding the application process, please contact Jason Yeh, Director PGY2 Oncology Pharmacy Residency program via email PGY2-OncologyResidency@mdanderson.org or phone 713-563-4838.

 

_{MD Anderson does not discriminate on the basis of race, sex, color, national and ethnic origin, handicap, or age in administration of its administrative policies, admission policies, and other school administered programs. MD Anderson is a tobacco-free environment.}